Abstract:Objectives Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. Study Design The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Results Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. Conclusions IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP. Our previous studies have shown that interleukin-6 (IL-6) is overexpressed in the saliva of patients with oral lichen planus (OLP) and is positively correlated with severity of disease. IL-6 may be associated with immune imbalance in patients with OLP. The purpose of the present study was to investigate the inhibitory effect of IL-6 on regulatory T cells (Treg) derived from patients with OLP. The diagnosis of OLP was acquired on the basis of both clinical and pathologic manifestations. Peripheral blood and its cultured supernatants were detected by using cytometric beads assay. The expression of IL-6 in local lesions was detected by using immunohistochemistry. The inhibition effect of OLP-derived or healthy-derived Treg on the proliferation of T effector cells (Teff) was detected by using flow cytometry; The OLP-derived Treg inhibition effect was detected after upregulating or neutralizing IL-6. Plasma IL-6 concentration in 31 patients with OLP was 10660.00 ± 7205.00 fg/mL, which was significantly higher than that in the healthy control group (325.70 ± 32.28 fg/mL; n = 11; P < .05). It was also higher in ex vivo cultured supernatants of patient-derived Teff than those of healthy controls (133.60 ± 30.01 μg/mL vs 34.94 ± 11.47 μg/mL; n = 6; P < .05). IL-6 was also overexpressed in local lesions than in healthy controls. In a co-culture experiment, the inhibition rate of OLP-derived Treg against proliferation of autologous Teff was 36.15% ± 4.78%, which was significantly lower than that in the healthy control group by 57.75% ± 6.68% (P < .05; n = 6). When IL-6 was added to healthy-derived Treg, the inhibition rate decreased to 32.92% ± 5.54%; after neutralizing IL-6 in OLP-derived Treg, the inhibition rate went up to 55.32% ± 5.13%. IL-6 was elevated in peripheral blood and local lesions in patients with OLP. In vitro, the inhibition effect of Treg on proliferation of autologous Teff in patients with OLP was significantly lower than that in healthy controls. This phenotype could be reversed in vitro when neutralizing IL-6. IL-6 may be an important factor affecting the immune homeostasis in OLP.

The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

Interferon-γ activated T-cell IRGM-autophagy axis in oral lichen planus

Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

Overexpressed Interleukin-6 Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus: an in Vitro Study

Single-cell immune profiling reveals immune responses in oral lichen planus

Altered Expression of Interleukin-17A and Its Targeting Micrornas in Oral Lichen Planus: a Pilot Study.

Identification of Potential Crucial Immune-related Genes and Key Pathways in Oral Lichen Planus

Increased pathogenicity and pro-inflammatory capabilities of mucosal-associated invariant T cells involved in Oral Lichen Planus

Direct immunofluorescence and immune function in patients with oral lichen planus

Identification of Potential Key Biomarkers and Immune Infiltration in Oral Lichen Planus

Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment

Characterizing inducible tertiary lymphoid structures in oral lichen planus: implications for stromal-immune cells interaction and disease severity

Aberrant Expression of Interleukin-22 and Its Targeting Micrornas in Oral Lichen Planus: a Preliminary Study.

Intralesional and peripheral plasma of oral lichenoid reactions exhibit different cytokine profiles: A preliminary study

Effects of PD-L2-Ig in the co-culture model of keratinocytes and T lymphocytes

The High Expression Level of Programmed Death-1 Ligand 2 in Oral Lichen Planus and the Possible Costimulatory Effect on Human T Cells

Aberrant Activation of the STING-TBK1 Pathway in γδ T Cells Regulates Immune Responses in Oral Lichen Planus

Mixed and Inhomogeneous Expression Profile of Th1/Th2 Related Cytokines Detected by Cytometric Bead Array in the Saliva of Patients with Oral Lichen Planus.

Increased Infiltration of CD11 C+/cd123+ Dendritic Cell Subsets and Upregulation of TLR/IFN-α Signaling Participate in Pathogenesis of Oral Lichen Planus.

Reveals of quercetin’s therapeutic effects on oral lichen planus based on network pharmacology approach and experimental validation